Related MeSH Hierarchy (11)
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Kidney Diseases » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urologic Neoplasms » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Complex and Mixed » Wilms Tumor
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Wilms Tumor
Diseases [C] » Neoplasms [C04] » Neoplastic Syndromes, Hereditary » Wilms Tumor
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Neoplastic Syndromes, Hereditary » Wilms Tumor
Description
A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem (blastemal), stromal (STROMAL CELLS), and epithelial (EPITHELIAL CELLS) elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child's side or ABDOMEN. MeSH
Hierarchy View
Subtype Terms (2)
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (34)
Phase 1 Indicated Drugs (31)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (14)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
